A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma

Overview of attention for article published in Journal of Negative Results in BioMedicine, June 2013

Altmetric Badge

About this Attention Score

Among the highest-scoring outputs from this source (#36 of 112)
Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

facebook: 2 Facebook pages

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 50 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Phleum pratense

Cited by Canadian Agency for Drugs and Technologies in Health on 04 Dec 2014

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.